lenalidomide,tafasitamab
morphosys,incyte
['tafasitamab-cxix', 'tafasitamab', 'monjuvi', 'lymphoma', 'l-mind', 'morphosys', 'incyte']
morphosys and incyte presents five-year p-ii study (l-mind) results of monjuvi (tafasitamab-cxix) for relapsed or refractory diffuse large b-cell lymphoma aacr 2023 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds